Navigation Links
Pasteuria Bioscience to be Acquired by Syngenta
Date:9/19/2012

ALACHUA, Fla., Sept. 19, 2012 /PRNewswire/ -- Pasteuria Bioscience has announced that it will be acquired by Syngenta, one of the world's leading agricultural technology companies.  In 2011 Syngenta and Pasteuria Bioscience entered into a global exclusive technology partnership to produce nematode control products based on Pasteuria spp., a naturally-occurring soil bacteria long recognized as a promising biological control agent against nematodes.  The first products resulting from this relationship will be available in 2014.

Under terms of the agreement, Syngenta will acquire Pasteuria Bioscience for aggregate payments of $86 million, plus up to $27 million in deferred payments.

"Pasteuria Bioscience is excited to become part of the Syngenta team.  We've been working closely together over the past year and have made significant progress on a number of nematode control products in a variety of crops.  Syngenta recognizes the potential with the Pasteuria platform and can commercialize it in a broad range of products for the global marketplace," said Al Kern, Executive Chairman and President of Pasteuria Bioscience.

Nematodes are a major pest across all crops and there are few commercial products available making it one of agriculture's largest unmet pest control needs.  This acquisition will facilitate the introduction of key products, including a seed treatment product for Soybean Cyst Nematode (SCN) which will complement Syngenta's existing nematicide line. 

"Results from our partnership have shown that Pasteuria provides superior control of nematodes in a wide variety of applications.  Pasteuria Bioscience has developed critical knowhow for in vitro production of Pasteuria, enabling commercial scale manufacturing.  This is a further example of our strategy to incorporate biological controls within our integrated offer to growers," said John Atkin, COO of Syngenta.

About Pasteuria Bioscience

Pasteuria Bioscience, Inc., was founded in 2003 in the University of Florida's Sid Martin Biotechnology Incubator where it remains headquartered.  The company was developed to commercialize its revolutionary technology for production of biological nematode control products based on the Pasteuria platform.  The first Pasteuria-based product, Econem®, was commercialized in 2010 for sting nematode control in the golf and sports turf markets.  Pasteuria Bioscience is also developing products to treat major nematode pests in most agricultural crops such as soybean, sugar beet and cotton as well as in specialty crops such as fruits and vegetables.  For more information, visit the Pasteuria Bioscience web site at http://www.pasteuriabio.com.

Note to the editor:

Learn more about Syngenta http://www.syngenta.com.


'/>"/>
SOURCE Pasteuria Bioscience
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Syngenta to acquire Pasteuria Bioscience
2. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
5. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
6. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
7. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
8. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
9. Ohios Bioscience Industry Effort Paying Off With Increase in Graduates and Accolades for the State
10. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
11. Roka Bioscience Secures $47.5 Million in Series D Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016   BioInformant ... report, "Stem Cell Research Products, Opportunities, Tools, and Technologies ... ... in the stem cell industry, BioInformant has more than ... the stem cell market, by stem cell type. This ...
(Date:2/10/2016)... - BioAmber Inc. (NYSE: BIOA ), a leader ... & Co. Ltd., its partner in the ... an additional CDN$25 million in the joint venture for ... to 40%.  Mitsui will also play a stronger role ... Sarnia , providing dedicated resources alongside BioAmber,s ...
(Date:2/10/2016)... is introducing a hybrid membership model which will provide ... joining or renewing through an organizational purchasing model. For ... employee in any size association or AMC office can ... benefits.   John H. Graham, IV , ... organizations of any size and their employees to gain ...
(Date:2/10/2016)... Feb. 10, 2016  Matchbook, Inc., a company ... growing biotech companies, announced today the appointment of ... Advisor. Jim brings nearly 25 years of experience ... having spent nearly two decades in executive level ... Procurement at Genzyme and, most recently headed global ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
(Date:1/25/2016)... 25, 2016   Unisys Corporation (NYSE: UIS ) ... Kennedy (JFK) International Airport, New York City , ... imposters attempting to enter the United States ... pilot testing of the system at Dulles last ... at JFK during January 2016. --> pilot testing ...
Breaking Biology News(10 mins):